Moleculin Biotech, Inc. Variable Lease, Cost
Moleculin Biotech, Inc. (MBRX) reported Variable Lease, Cost of $7.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-13
- Moleculin Biotech, Inc. variable lease, cost for the quarter ending 2026-06-30 was $7.00K, a 0.00% change year-over-year.
- Moleculin Biotech, Inc. variable lease, cost for the quarter ending 2026-03-31 was $7.00K, a 0.00% change year-over-year.
- Moleculin Biotech, Inc. variable lease, cost for the quarter ending 2025-12-31 was $7.00K, a 0.00% change year-over-year.
- Moleculin Biotech, Inc. variable lease, cost for the quarter ending 2025-09-30 was $7.00K, a 0.00% change year-over-year.
- Moleculin Biotech, Inc. variable lease, cost for fiscal 2025 was $29.00K, a 20.83% increase from fiscal 2024.
- Moleculin Biotech, Inc. variable lease, cost for fiscal 2024 was $24.00K, a 26.32% increase from fiscal 2023.
- Moleculin Biotech, Inc. variable lease, cost for fiscal 2023 was $19.00K, a 34.48% decline from fiscal 2022.
- Moleculin Biotech, Inc. variable lease, cost for fiscal 2022 was $29.00K, a 0.00% change from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 6 month as first filed | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.00K 10-Q · filed 2026-08-13 | $14.00K 10-Q · filed 2026-08-13 | $21.00K derived: sum of 3 quarters · filed 2026-08-13 | $28.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-14 | $14.00K derived: sum of 2 quarters · filed 2026-05-14 | $21.00K derived: sum of 3 quarters · filed 2026-05-14 | $28.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $14.00K derived: sum of 2 quarters · filed 2026-03-18 | $21.00K derived: sum of 3 quarters · filed 2026-08-13 | $29.00K 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-13 | $14.00K derived: sum of 2 quarters · filed 2026-08-13 | $22.00K 10-Q · filed 2025-11-13 | $28.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $7.00K 10-Q · filed 2026-08-13 | $14.00K 10-Q · filed 2026-08-13 | $21.00K derived: sum of 3 quarters · filed 2026-08-13 | $28.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-14 | $14.00K derived: sum of 2 quarters · filed 2026-05-14 | $21.00K derived: sum of 3 quarters · filed 2026-05-14 | $28.00K derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $14.00K derived: sum of 2 quarters · filed 2026-03-18 | $21.00K derived: sum of 3 quarters · filed 2026-03-18 | $24.00K 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $7.00K 10-Q · filed 2025-11-13 | $14.00K derived: sum of 2 quarters · filed 2025-11-13 | $17.00K 10-Q · filed 2025-11-13 | $16.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $7.00K 10-Q · filed 2025-08-12 | $10.00K 10-Q · filed 2025-08-12 | $9.00K derived: sum of 3 quarters · filed 2025-08-12 | $14.00K derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $2.00K 10-Q · filed 2025-05-13 | $2.00K derived: sum of 2 quarters · filed 2025-05-13 | $7.00K derived: sum of 3 quarters · filed 2025-05-13 | $14.00K derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $5.00K derived: sum of 2 quarters · filed 2025-03-21 | $12.00K derived: sum of 3 quarters · filed 2025-03-21 | $19.00K 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | $5.00K 10-Q · filed 2024-11-08 | $12.00K derived: sum of 2 quarters · filed 2024-11-08 | $19.00K 10-Q · filed 2024-11-08 | $26.00K derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $7.00K 10-Q · filed 2024-08-13 | $14.00K 10-Q · filed 2024-08-13 | $21.00K derived: sum of 3 quarters · filed 2024-08-13 | $28.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $7.00K 10-Q · filed 2024-05-10 | $14.00K derived: sum of 2 quarters · filed 2024-05-10 | $21.00K derived: sum of 3 quarters · filed 2024-05-10 | $28.00K derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $14.00K derived: sum of 2 quarters · filed 2024-03-22 | $21.00K derived: sum of 3 quarters · filed 2024-03-22 | $29.00K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | $7.00K 10-Q · filed 2023-11-13 | $14.00K derived: sum of 2 quarters · filed 2023-11-13 | $22.00K 10-Q · filed 2023-11-13 | $28.00K derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $7.00K 10-Q · filed 2023-08-10 | $14.00K 10-Q · filed 2023-08-10 | $21.00K derived: sum of 3 quarters · filed 2023-08-10 | $28.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $7.00K 10-Q · filed 2023-05-10 | $14.00K derived: sum of 2 quarters · filed 2023-05-10 | $21.00K derived: sum of 3 quarters · filed 2023-05-10 | $28.00K derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $14.00K derived: sum of 2 quarters · filed 2023-03-22 | $21.00K derived: sum of 3 quarters · filed 2023-03-22 | $29.00K 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-10 | $14.00K derived: sum of 2 quarters · filed 2022-11-10 | $22.00K 10-Q · filed 2022-11-10 | $28.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $7.00K 10-Q · filed 2022-08-12 | $14.00K 10-Q · filed 2022-08-12 | $21.00K derived: sum of 3 quarters · filed 2022-08-12 | $28.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $7.00K 10-Q · filed 2022-05-11 | $14.00K derived: sum of 2 quarters · filed 2022-05-11 | $21.00K derived: sum of 3 quarters · filed 2022-05-11 | $28.00K derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $14.00K derived: sum of 2 quarters · filed 2022-03-24 | $21.00K derived: sum of 3 quarters · filed 2022-03-24 | $29.00K 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $7.00K 10-Q · filed 2021-11-10 | $14.00K derived: sum of 2 quarters · filed 2021-11-10 | $22.00K 10-Q · filed 2021-11-10 | $29.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $7.00K 10-Q · filed 2021-08-11 | $14.00K 10-Q · filed 2021-08-11 | $22.00K derived: sum of 3 quarters · filed 2021-08-11 | $29.00K derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $7.00K 10-Q · filed 2021-05-12 | $15.00K derived: sum of 2 quarters · filed 2021-05-12 | $22.00K derived: sum of 3 quarters · filed 2021-05-12 | $29.00K derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | $15.00K derived: sum of 2 quarters · filed 2021-03-24 | $22.00K derived: sum of 3 quarters · filed 2021-03-24 | $27.00K 10-K · filed 2021-03-24 | $30.00K 10-K · filed 2020-03-19 | |||
| 2019-09-30 | $7.00K 10-Q · filed 2020-11-12 | $10.00K 10-Q · filed 2019-11-12 | $14.00K derived: sum of 2 quarters · filed 2020-11-12 | $19.00K 10-Q · filed 2020-11-12 | $20.00K 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $7.00K 10-Q · filed 2020-08-12 | $10.00K 10-Q · filed 2019-08-16 | $12.00K 10-Q · filed 2020-08-12 | $10.00K 10-Q · filed 2019-08-16 | ||||
| 2019-03-31 | $5.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |